Dementia Not Prevented with Vitamin E, Selenium, Study Finds – Medical News Today

An ample body of research has shown that oxidative stress plays a key role in the development of neurodegenerative disorders such as Alzheimer’s and Parkinson’s disease. As a result, antioxidant supplements have been proposed as preventive measures against dementia. A new trial, however, tests the effect of vitamin E and selenium on aging men and finds no evidence that they have therapeutic value.

Read more


When the Boss Is Half Your Age – The New York Times

Companies these days are looking to fill the management ranks with people who are “digital natives,” which frequently translates to millennials and Gen X-ers. Meanwhile, more baby boomers are staying on the job longer, and some retirees, looking for a second act, are rejoining the ranks of the employed, at least part time. Consequently, the odds are increasing that older workers will be answering to managers young enough to be their children.

Read more

Screen Shot 2017-03-14 at 8.52.18 PM

Here’s an ‘income menu’ that could help retirees make their savings last – MarketWatch


Sudden Drops in Blood Pressure May Increase Risk of Dementia – Medical News Today

Dementia affects tens of millions of people in the United States. New research suggests that those who experience sudden blood pressure drops in their middle age may be more likely to develop dementia in old age.

Read more


Researchers Shift Focus to Prevention of Alzheimer’s – The Globe and Mail

It’s been 10 years since Vancouver resident Jim Mann was diagnosed with Alzheimer’s. In that time, multiple experimental drugs have emerged with new hopes of beating back his disease. Yet none has resulted in a viable clinical treatment.

Read more


Employers are Trying to Solve Their Workers’ Retirement Income Problem –MarketWatch

We already know the bad news: The disappearance of traditional pension plans has contributed to a retirement crisis in the U.S., in part because of increased risk that an investor will outlive her savings. Anyone lucky enough to have a retirement plan at work these days — more than one-third of private-sector workers lack access will likely have a defined-contribution plan, such as a 401(k). Those plans can present big hurdles come retirement time, when investors must determine how much they can safely withdraw so their nest egg lasts long enough. Now, some better news: Private-sector companies are waking up to the problem.

Read more


IBM Wants to Protect Senior Citizens by Tracking Nearly Their Every Move – Business Insider

Over the last several years, the computing giant has spent much of its time researching ways to keep America’s second-largest generation happy and healthy in old age. That research has zeroed in on outfitting boomers’ living spaces with artificially-intelligent sensors that can measure things like air quality, sleep quality, movement patterns, falls, and changes in scent and sound.

Read more


The Retirement Crisis Facing African Americans – Forbes

There’s a saying: When white America catches a cold, black America catches pneumonia. So, if there is an impending retirement crisis in America, what does that mean for African Americans? The answer to that question is discouraging.

Read more


Diabetes Drug Might Help Detect and Treat Alzheimer’s Disease – Pharmaceutical Processing

As the number of patients with Alzheimer’s disease (AD) rapidly increases, new treatments as well as blood tests that are simple and can be easily performed in a doctor’s office to diagnose are urgently needed. A new study has found treatment with the diabetes drug amylin (or pramlintide) safely improves learning and memory function in AD patients and reduces the AD pathology in their brains.

Read more


Big Alzheimer’s Research Roadblock: Federal government – CNBC

Promising new research conducted last year at the Salk Institute for Biological Studies has shown that marijuana extracts may hold a key to treating Alzheimer’s disease. The next step: To conduct tests on mice and, if the results are promising, move on to human trials. But Salk Institute researchers have run into a major hurdle, and not a scientific one: the federal government.

Read more